Brought to you by 
Inverness buys Panbio for $37mm
16 Jan 2008
Executive Summary
Inverness Medical Innovations has acquired all outstanding shares of infectious disease diagnostics firm Panbio Ltd. for $37mm ($A41mm) in cash, paying $0.58 per share (a 4% premium).
Deal Industry
- Biotechnology
- In Vitro Diagnostics
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Intra-Biotech Deal
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com